Potential Inhibitors of SARS-CoV-2 Main Protease (Mpro) Identified from the Library of FDA-Approved Drugs Using Molecular Docking Studies.
Biomedicines
; 11(1)2022 Dec 29.
Article
in En
| MEDLINE
| ID: mdl-36672593
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Guideline
/
Prognostic_studies
Language:
En
Journal:
Biomedicines
Year:
2022
Document type:
Article
Affiliation country:
India
Country of publication:
Switzerland